These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 37839012

  • 1. [Correlation of FGF2 and TGF-β1 with benign prostatic hyperplasia: Progress in research].
    Luo H, Wei Q.
    Zhonghua Nan Ke Xue; 2022 Sep; 28(9):843-847. PubMed ID: 37839012
    [Abstract] [Full Text] [Related]

  • 2. Benign prostatic stromal cells are regulated by basic fibroblast growth factor and transforming growth factor-beta 1.
    Collins AT, Robinson EJ, Neal DE.
    J Endocrinol; 1996 Nov; 151(2):315-22. PubMed ID: 8958793
    [Abstract] [Full Text] [Related]

  • 3. MIR663AHG as a competitive endogenous RNA regulating TGF-β-induced epithelial proliferation and epithelial-mesenchymal transition in benign prostate hyperplasia.
    Tong S, Mo M, Hu X, Wu L, Chen M, Zhao C.
    J Biochem Mol Toxicol; 2023 Sep; 37(9):e23391. PubMed ID: 37518988
    [Abstract] [Full Text] [Related]

  • 4. Effect of beta radiation on TGF-beta1 and bFGF expression in hyperplastic prostatic tissues.
    Ma QJ, Gu XQ, Cao X, Zhao J, Kong XB, Li YX, Cai SY.
    Asian J Androl; 2005 Mar; 7(1):49-54. PubMed ID: 15685352
    [Abstract] [Full Text] [Related]

  • 5. Tight junction protein claudin-1 is downregulated by TGF-β1 via MEK signaling in benign prostatic epithelial cells.
    Wang K, Pascal LE, Li F, Chen W, Dhir R, Balasubramani GK, DeFranco DB, Yoshimura N, He D, Wang Z.
    Prostate; 2020 Oct; 80(14):1203-1215. PubMed ID: 32692865
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities.
    Timme TL, Yang G, Truong LD, Kadmon D, Park SH, Thompson TC.
    World J Urol; 1995 Oct; 13(6):324-8. PubMed ID: 9116750
    [Abstract] [Full Text] [Related]

  • 7. Cooperative effects of EGF, FGF, and TGF-β1 in prostate stromal cells are different from responses to single growth factors.
    Hennenberg M, Schreiber A, Ciotkowska A, Rutz B, Waidelich R, Strittmatter F, Stief CG, Gratzke C.
    Life Sci; 2015 Feb 15; 123():18-24. PubMed ID: 25529149
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M, De Miguel MP, Bethencourt FR, Sanchez-Chapado M, Fraile B, Paniagua R.
    Growth Factors; 1998 Feb 15; 16(2):101-10. PubMed ID: 9932228
    [Abstract] [Full Text] [Related]

  • 9. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
    Hu S, Yu W, Lv TJ, Chang CS, Li X, Jin J.
    Mol Membr Biol; 2014 Feb 15; 31(2-3):103-10. PubMed ID: 24650126
    [Abstract] [Full Text] [Related]

  • 10. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway.
    Kim HJ, Jin BR, An HJ.
    Biomed Pharmacother; 2023 Apr 15; 160():114389. PubMed ID: 36791565
    [Abstract] [Full Text] [Related]

  • 11. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
    Soulitzis N, Karyotis I, Delakas D, Spandidos DA.
    Int J Oncol; 2006 Aug 15; 29(2):305-14. PubMed ID: 16820871
    [Abstract] [Full Text] [Related]

  • 12. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G, Gander R, Lilg C, Lepperdinger G, Plas E, Berger P.
    Mech Ageing Dev; 2005 Jan 15; 126(1):59-69. PubMed ID: 15610763
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
    Giri D, Ittmann M.
    Am J Pathol; 2001 Jul 15; 159(1):139-47. PubMed ID: 11438462
    [Abstract] [Full Text] [Related]

  • 14. Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.
    Wang L, Xie L, Tintani F, Xie H, Li C, Cui Z, Wan M, Zu X, Qi L, Cao X.
    Stem Cells Transl Med; 2017 Feb 15; 6(2):394-404. PubMed ID: 28191756
    [Abstract] [Full Text] [Related]

  • 15. Apoptotic versus proliferative activities in human benign prostatic hyperplasia.
    Kyprianou N, Tu H, Jacobs SC.
    Hum Pathol; 1996 Jul 15; 27(7):668-75. PubMed ID: 8698310
    [Abstract] [Full Text] [Related]

  • 16. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
    Zhou J, Lei Y, Chen J, Zhou X.
    Int Immunopharmacol; 2018 Nov 15; 64():162-169. PubMed ID: 30179845
    [Abstract] [Full Text] [Related]

  • 17. Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat.
    Shimizu S, Shimizu T, Tsounapi P, Higashi Y, Martin DT, Nakamura K, Honda M, Inoue K, Saito M.
    PLoS One; 2015 Nov 15; 10(8):e0133798. PubMed ID: 26308715
    [Abstract] [Full Text] [Related]

  • 18. Cellular localization of fibroblast growth factor 2 (FGF-2) in benign prostatic hyperplasia.
    Sinowatz F, Schams D, Einspanier R, Arnold G, Pfeffer M, Temmim-Baker L, Amselgruber W, Plendl J.
    Histol Histopathol; 2000 Apr 15; 15(2):475-81. PubMed ID: 10809367
    [Abstract] [Full Text] [Related]

  • 19. Retroviral transduction of transforming growth factor-beta1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutions.
    Timme TL, Yang G, Rogers E, Kadmon D, Morganstern JP, Park SH, Thompson TC.
    Lab Invest; 1996 Apr 15; 74(4):747-60. PubMed ID: 8606485
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro.
    Zhao Y, Peng J, Zheng L, Yu W, Jin J.
    Prostate; 2010 Jun 01; 70(8):899-905. PubMed ID: 20135646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.